Preliminary scientific programme


17.00h - 19.00h   Welcome to the 16th PCDE Conference
                             Afternoon satellite symposium. Advancing Strategies in the Management of Type 2 Diabetes
Sponsored by Worldwide Initiative for Diabetes Education
                             More information


8.00h - 9.00h       Breakfast satellite symposium.                          
                             Sponsored by Boehringer Ingelheim and Eli Lilly and Company Alliance
                             More information

9.00h - 9.15h       Opening of the scientific programme

9.15h - 10.00h     Session 1. Diabetes in the young and elderly

  • Diabetes in the young - Sam Seidu (UK)
  • Diabetes in the elderly - Guy Rutten (Netherlands)

10.00h - 10.40h   Session 2. Oral presentation of best abstracts

10.45h - 11.30h   Coffee break and poster walk #1

11.30h - 12.20h   Session 3. Controlling traditional modifiable CVD risk factors in T2DM. Latest state of evidence.

  • Pharmacotherapy - lipids - TBA
  • Pharmacotherapy - blood pressure: evidence beyond the ACCORD trial? - Carlos Brotons (Spain)

12.20h - 13.00h   Session 4. Paul Cromme lecture. Life time achievement award

  • David Matthews (UK)

13.00h - 14.30h   Lunch satellite symposium
                             Sponsored by Lilly Diabetes
                            (more information available soon)

14.30h - 15.15h   Session 5. Keynote lecture. New agents of T2DM: Incretin pathway

  • Melanie Davies (UK)

15.15h - 16.30h   Session 6. Presentation on the PCDE consensus report on the disease state approach on the pharmacological management of hyperglycaemia in type 2 diabetes

  • Rationale and methodology of the consensus report - Sam Seidu (UK)
  • Discuss the the rationale for the risk stratification used and the subgroups of patients to treat - Kamlesh Khunti (UK)
  • Our main recommendations for the various subgroups - Stefan Jansson (Sweden)
  • Implications for practice - Manel Mata (Spain)

16.30h - 17.00h   Session 7. Top 5 in diabetes (Best 5 papers of the year in PCD Journal)

17.00h - 18.00h   Afternoon satellite symposium. Emerging therapies for T2D in primary care                      

  • New and emerging therapies for T2D
  • Treatment options after metformin
  • Investigating semaglutide in renal impairment and late stage disease
  • Cardiovascular outcomes with semaglutide: current and future insights
  • Q&A

Sponsored by Novo Nordisk


8.00h - 9.00h       Breakfast satellite symposium.
                             Sponsored by Medtronic
                             (More information available soon)

9.00h - 9.30h      Session 8. Rising star lecture

9.30h - 10.15h    Session 9. Diabetes remission

  • Lifestyle - George Thom (UK)
  • Bariatric surgery - Josep Vidal (Spain)

10.15h - 11.00h  Coffee break and poster walk #2

11.00h - 12.00h  Session 10. A Decade of Experience. Update on cardiovascular outcome trials in T2DM

  • Renal outcomes - TBA
  • Heart Failure - TBA
  • How does CVOT evidence translate into clinical practice:update on guidelines - Kamlesh Khunti (UK)

12.00h - 12.15h  Closing ceremony

12.30h  Reception (informal drink and tapas)